EPA Delays Decisions on 'Forever Chemicals'

The U.S. Environmental Protection Agency (EPA) has paused decisions on uses for dozens of "forever chemicals," also known as PFAS.

The delay includes proposed changes regarding how several of these chemicals can be used, according to one of two people familiar with the situation who spoke to The Washington Post. The two commented ...

Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans

Buying or selling wild animals, whether for food, pets or other uses, may increase the risk of diseases spreading to people, a new study finds.

Researchers looked at more than 40 years of global wildlife trade data and thousands of mammal species. They found that animals involved in the trade were 50% more likely to carry germs that can in...

Yes, This is the Worst Pollen Season Ever — Until Next Year

When I was training to be a board-certified allergist 20 years ago, a running joke cropped up every spring. Local media outlets loudly proclaimed the worst pollen season ever!

Spring is when trees release microscopic pollen into the air, causing misery for the tens of millions of people living with seasonal allergies and asthma.

We...

New Weight Loss Pill Gets Approval But FDA Seeks More Safety Data

The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, according to an approval letter released Tuesday.

Foundayo was approved earlier this month through an FDA pilot program designed to speed up drug reviews. 

It is the second oral GLP...

An Infectious Combo Triples Risk Of MS, Study Says

An Epstein-Barr virus infection that results in a case of mono appears to triple the risk of one day developing multiple sclerosis, a new study says.

Epstein-Barr, a herpes virus, is the most common cause of infectious mononucleosis, researchers said.

Now, it seems that one-two punch might increase the risk of the degenerative brain ...

Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes

A blood test can predict Alzheimer’s disease progression in a person’s brain years before they show any symptoms of decline, a new study says.

The test, which looks for a form of toxic tau protein in the blood, reveals Alzheimer’s risk long before brain scans start to show signs of deterioration, researchers reported Apri...